RETRACTED: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings

Dobriyan, Alex; Gluck, Iris; Alon, Eran; Barshack, Iris; Yahalom, Ran; Vered, Marilena

doi:10.3389/froh.2021.653104

ORIGINAL RESEARCH article

Front. Oral. Health , 23 April 2021

Sec. Oral Cancers

Volume 2 - 2021 | https://doi.org/10.3389/froh.2021.653104

This article is part of the Research Topic The Translational and Therapeutic Potential of the Tumor Microenvironment in Oral Cancer View all 11 articles

RETRACTED: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings

Retracted

A retraction of this article was approved in:

Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
1. Read retraction

$\r\nAlex Dobriyan$ Alex Dobriyan¹

Iris Gluck^2,3

Eran Alon^3,4

Iris Barshack^3,5

Ran Yahalom¹

Marilena Vered^5,6^*

¹Department of Oral and Maxillofacial Surgery, The Chaim Sheba Medical Center, Tel Hashomer, Israel
²Head and Neck Cancer Unit, The Chaim Sheba Medical Center, Institute of Oncology, Tel Hashomer, Israel
³Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Department of Otolaryngology—Head and Neck Surgery, The Chaim Sheba Medical Center, Tel Hashomer, Israel
⁵The Chaim Sheba Medical Center, Institute of Pathology, Tel Hashomer, Israel
⁶Department of Oral Pathology, Oral Medicine and Maxillofacial Imaging, School of Dentistry, Tel Aviv University, Tel Aviv, Israel

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Dobriyan A, Gluck I, Alon E, Barshack I, Yahalom R and Vered M (2021) Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings. Front. Oral. Health 2:653104. doi: 10.3389/froh.2021.653104

Received: 13 January 2021; Accepted: 22 March 2021;
Published: 23 April 2021; Retracted: 22 March 2022.

Edited by:

Ricardo D. Coletta, Campinas State University, Brazil

Reviewed by:

Tine M. Søland, University of Oslo, Norway
Luiz Alcino Gueiros, Federal University of Pernambuco, Brazil

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

RETRACTED: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good